Cure My Disease

Don't miss your cure!

 Log in / Sign up

Shoulder replacement or not? new study for seniors with complex fractures

NCT ID NCT03531463

Disease control Sponsor: Oslo University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at two ways to treat serious shoulder fractures in people aged 65 to 85: a reverse total shoulder replacement (surgery) or non-surgical care like a sling and physical therapy. The goal is to see which approach leads to better arm and shoulder function and quality of life. About 154 participants are being followed for at least two years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

154 people

The number who actually took part.

Started

Oct 2018

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Low energy AO/OTA group 11-B1.1, 11-B1.2 and 11-C1.1, 11-C3.1. Both B and C type includes subgroups: Displaced \[2\], Impacted \[3\] or Non impacted \[4\] from the universal modifiers list. Exclusion Criteria: Radiographic Mal-inclination Less than; varus 30°or valgus 45° Less than 50% contact between head fragment and meta-/diaphysis Head split fractures with more than 10% of the articular surface in the main head fragment. Head split fractures (group 11-C3.2 and 11-C3.3) with more than 10% of the articular surface in the main head fragment. Dislocation or fracture-dislocation of the gleno-humeral joint Pathological fracture General * Refuse to participate * Age under 65 years of age, or over 85 years of age * Serious poly-trauma or additional surgery * Non-independent, drug/alcohol abuse or institutionalized (low co-operation) * Contra-indications for surgery * Does not understand written and spoken guidance in local languages * Previous fracture with symptomatic sequelae in either shoulder * Patients living outside the hospital's catchment area

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Proximal humeral fracture are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

humerus fracture Shoulder Fractures

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Proximal humeral fracture

Contacts and locations

Locations

  • Aarhus University Hospital, Division of Orthopaedics

    Aarhus, Denmark

  • Oslo University Hospital, Division of Orthopaedics

    Oslo, Norway

  • Tampere University Hospital, Division of Orthopaedics

    Tampere, Finland

More trials for these conditions

Other studies related to the condition(s) this trial covers.